Janus Henderson Group plc Reports New 5.1% Stake in Bicara Therapeutics Inc. (BCAX)

On May 15, 2026, Janus Henderson Group plc filed a Schedule 13G reporting a new 5.1% ownership stake in Bicara Therapeutics Inc. (BCAX). The filing indicates that Janus Henderson Group plc beneficially owns 3,339,218 shares of common stock as of the event date on March 31, 2026. This position was acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Janus Henderson Group plc serves as the ultimate parent company for several SEC-registered investment advisers, including Janus Henderson Investors US LLC and Janus Henderson Investors UK Limited, which exercise investment and voting discretion over the shares on behalf of various managed portfolios. The filing reports shared voting and dispositive power over all 3,339,218 shares. No individual managed portfolio under the group's umbrella owns more than 5% of the issuer's common stock. This filing marks an increase from a previous ownership level of 0.0%.